IS8231A - Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða - Google Patents

Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða

Info

Publication number
IS8231A
IS8231A IS8231A IS8231A IS8231A IS 8231 A IS8231 A IS 8231A IS 8231 A IS8231 A IS 8231A IS 8231 A IS8231 A IS 8231A IS 8231 A IS8231 A IS 8231A
Authority
IS
Iceland
Prior art keywords
carboxylic acid
acid derivatives
pharmaceutically useful
useful salts
salts
Prior art date
Application number
IS8231A
Other languages
English (en)
Inventor
Aurell Carl-Johan
Dahlström Mikael
Lindstedt-Alstermark Eva-Lotte
Minidis Anna
Ohlsson Bengt
Ståhle Erica
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS8231A publication Critical patent/IS8231A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS8231A 2003-06-18 2006-01-13 Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða IS8231A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0314129.8A GB0314129D0 (en) 2003-06-18 2003-06-18 Therapeutic agents
PCT/SE2004/000964 WO2004110984A1 (en) 2003-06-18 2004-06-16 Pharmaceutically useful salts of carboxylic acid derivates

Publications (1)

Publication Number Publication Date
IS8231A true IS8231A (is) 2006-01-13

Family

ID=27636788

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8231A IS8231A (is) 2003-06-18 2006-01-13 Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða

Country Status (23)

Country Link
US (1) US20060142389A1 (is)
EP (1) EP1638922A1 (is)
JP (1) JP3822900B1 (is)
KR (1) KR20060027348A (is)
CN (1) CN1809529A (is)
AR (1) AR044801A1 (is)
AU (1) AU2004247610B2 (is)
BR (1) BRPI0411525A (is)
CA (1) CA2528932A1 (is)
CO (1) CO5650228A2 (is)
GB (1) GB0314129D0 (is)
IL (1) IL172167A0 (is)
IS (1) IS8231A (is)
MX (1) MXPA05013714A (is)
MY (1) MY137277A (is)
NO (1) NO20055922L (is)
RU (1) RU2005138590A (is)
SA (1) SA04250169B1 (is)
TW (1) TW200503677A (is)
UA (1) UA81807C2 (is)
UY (1) UY28375A1 (is)
WO (1) WO2004110984A1 (is)
ZA (1) ZA200510252B (is)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0104333D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
GB0229931D0 (en) * 2002-12-21 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0314079D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
SE0104334D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
JP3782818B2 (ja) 2002-06-20 2006-06-07 アストラゼネカ アクチボラグ インスリン抵抗性の処置のためのオルト置換安息香酸誘導体
SE0403072D0 (sv) * 2004-12-16 2004-12-16 Astrazeneca Ab Pharmaceutically useful salts of carboxylic acid derivates
WO2007004957A1 (en) * 2005-07-05 2007-01-11 Astrazeneca Ab Novel crystalline form
AR055073A1 (es) * 2005-07-11 2007-08-01 Astrazeneca Ab Agentes terapeuticos
MX2013014310A (es) 2011-06-06 2014-01-23 Akebia Therapeutics Inc Compuestos y composiciones para estabilizar el factor-2 alfa inducible por hipoxia como un metodo para tratar el cancer.
NO2686520T3 (is) 2011-06-06 2018-03-17
CN114404414A (zh) 2013-06-13 2022-04-29 阿克比治疗有限公司 用于治疗贫血症的组合物和方法
KR102495018B1 (ko) 2013-11-15 2023-02-06 아케비아 테라퓨틱스 인코포레이티드 ｛[5-(3-클로로페닐)-3-하이드록시피리딘-2-카보닐]아미노｝아세트산의 고체형, 이의 조성물 및 용도
EP3247355A4 (en) 2015-01-23 2018-06-13 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
EA036920B1 (ru) 2015-04-01 2021-01-15 Экебиа Терапьютикс, Инк. Композиции и способы для лечения анемии
TW202406895A (zh) 2018-05-09 2024-02-16 美商阿克比治療有限公司 用於製備2-[[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基]乙酸之方法
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020060067A (ko) * 1999-04-06 2002-07-16 가와무라 요시부미 α-치환 카르복실산 유도체
SE0104334D0 (sv) * 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents

Also Published As

Publication number Publication date
WO2004110984A1 (en) 2004-12-23
BRPI0411525A (pt) 2006-08-01
GB0314129D0 (en) 2003-07-23
CO5650228A2 (es) 2006-06-30
ZA200510252B (en) 2006-12-27
UA81807C2 (uk) 2008-02-11
AR044801A1 (es) 2005-10-05
AU2004247610A1 (en) 2004-12-23
TW200503677A (en) 2005-02-01
MY137277A (en) 2009-01-30
SA04250169B1 (ar) 2007-08-07
KR20060027348A (ko) 2006-03-27
US20060142389A1 (en) 2006-06-29
RU2005138590A (ru) 2006-07-27
AU2004247610B2 (en) 2008-04-17
MXPA05013714A (es) 2006-06-27
CA2528932A1 (en) 2004-12-23
SA04250169A (ar) 2005-12-03
EP1638922A1 (en) 2006-03-29
JP2006527766A (ja) 2006-12-07
IL172167A0 (en) 2009-02-11
UY28375A1 (es) 2005-01-31
NO20055922L (no) 2006-01-06
JP3822900B1 (ja) 2006-09-20
CN1809529A (zh) 2006-07-26

Similar Documents

Publication Publication Date Title
DK1660431T3 (da) Phenoxyeddikesyrederivater
IS8231A (is) Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða
ATE384696T1 (de) Mandelsäure derivate
NO20050884D0 (no) Ny fremgangsmate for syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
ATE517887T1 (de) Neue 2-pyridincarbonsäureamidderivate
DE50212761D1 (de) Neuartige aminodicarbonsäurederivate
CY2017048I2 (el) Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
NO20034669D0 (no) Karboksylsyrederivat og salt derav
NO20024387D0 (no) Karboksylsyrederivater som IP-antagonister
NO20043660L (no) Salter av valsartan
EP1765336A4 (en) ANGIOGENESIS INHIBITORS
ATE410407T1 (de) Zimtsäureamidderivate
NO20035694D0 (no) Nye sulfonsyrederivater
ATE384530T1 (de) 4-aminochinolin-3-carbonsäureamid-derivate als pde4-hemmer
NO20054763D0 (no) Salts of clopidogrel and process for preparation
DK1650186T3 (da) Nye dicarboxylsyrederivater
IS8232A (is) Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða
AP2076A (en) New Heterocyclic carboxylic acid amide derivatives
NO20055485D0 (no) Vannloselige salter av risperidon
SI1513806T1 (sl) Sulfonske kislinske soli derivatov mandljeve kisline
FI20020593A0 (fi) Menetelmä konjugoidun linolihapon valmistamiseksi
EP1829864A4 (en) ISOCHINOLINE DERIVATIVES AS CALPAININHIBITORS
NO20053673D0 (no) Nye antikonvulsanderivatsalter
NO20050183L (no) Farmasoytiske salter av reboxetin
DK1497290T3 (da) Fremgangsmåde til fremstilling af syresalte af gemifloxacin